UPDATED RESULTS OF A PHASE 2 STUDY FROM GELTAMO INVESTIGATING THE COMBINATION OF IBRUTINIB WITH R‐GEMOX IN PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B‐CELL LYMPHOMA. (17th June 2021) - Búa, B. Rey; Jiménez‐Ubieto, A.; Blanco, J. J. Sánchez; Abrisqueta, P.; Gutiérrez, A.; Ramírez‐Páyer, Án.; Giné, E.; Etxetxipia, I. Zeberio; Terol, M. José; Cruz, F. de la; Andreu, R.; Ramírez, M.; et al.